Clinical Trial Detail

NCT ID NCT02683395
Title A Study of PLX51107 in Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Plexxikon
Indications

myelodysplastic syndrome

acute myeloid leukemia

Advanced Solid Tumor

lymphoma

Therapies

PLX51107

Age Groups: senior adult

No variant requirements are available.